ARTICLE | Company News

PD company Prevail launches

August 9, 2017 10:13 PM UTC

RegenxBio Inc. (NASDAQ:RGNX), OrbiMed and The Silverstein Foundation for Parkinson’s with GBA launched Prevail Therapeutics Inc. (New York, N.Y.) to develop biologics to treat Parkinson's disease and other neurodegenerative disorders.

Prevail launches under a deal with RegenxBio, in which the newco gained exclusive, worldwide rights to develop and commercialize gene therapies utilizing RegenxBio's NAV AAV9 vector to treat PD and neurodegenerative diseases...

BCIQ Company Profiles

RegenxBio Inc.